Skip to main content

Quipt Home Medical Achieves Positive Growth and Expands Reach with Strategic Acquisition

Tipranks - Tipranks - Tue Aug 12, 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Quipt Home Medical ( (TSE:QIPT) ) just unveiled an announcement.

Quipt Home Medical reported its fiscal third quarter 2025 results, highlighting a return to positive organic growth with a 1.6% increase in quarter-over-quarter revenue, despite a year-over-year decrease. The company achieved an adjusted EBITDA of 23.5% of revenue and maintained strong recurring revenue at 81%. Operationally, Quipt expanded its reach through the acquisition of a durable medical equipment provider, enhancing its presence in the Appalachian Highlands region and securing a Preferred Provider Agreement with Ballad Health. This strategic move is expected to align the acquired operation’s margins with Quipt’s historical range, supporting long-term growth and stability.

The most recent analyst rating on (TSE:QIPT) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.

Spark’s Take on TSE:QIPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:QIPT is a Neutral.

Quipt Home Medical’s overall stock score is driven by strong revenue growth and cash flow management, despite profitability challenges. Technical indicators suggest stability, but valuation concerns due to negative earnings impact the score. The earnings call provided mixed insights, with strategic initiatives in place to address current challenges.

To see Spark’s full report on TSE:QIPT stock, click here.

More about Quipt Home Medical

Quipt Home Medical Corp. is a U.S.-based provider of home medical equipment, specializing in end-to-end respiratory care. The company focuses on delivering comprehensive respiratory solutions and services to patients across the United States.

Average Trading Volume: 43,518

Technical Sentiment Signal: Sell

Current Market Cap: C$127.7M

Find detailed analytics on QIPT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).